Santen Pharmaceutical Co Ltd (OTC Pink - Current Information:SNPHY)

13.42
Delayed Data
As of 2:12pm ET
 +0.09 / +0.68%
Today’s Change
8.87
Today|||52-Week Range
15.10
+25.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line366.4M352.9M308.9M267.9M
 
 
 
 
 
Depreciation35.1M37.5M39.7M39.1M
 
 
 
 
 
Total Other Cash Flow-136.9M-114.7M-144.4M-40.6M
 
 
 
 
 
Funds From Operations264.6M275.7M204.2M266.3M
 
 
 
 
 
Funds From/For Other Operating Expenses55.1M2.8M84.2M7.8M
 
 
 
 
 
Net Cash Flow - Operating Activities209.5M272.8M120.0M258.5M
 
 
 
 
 
 
InvestingIncrease In Investments-119.9M-53.4M-68.6M-49.3M
 
 
 
 
 
Decrease In Investments46.5M101.7M56.5M30.3M
 
 
 
 
 
Capital Expenditures-19.5M-41.7M-43.5M-47.7M
 
 
 
 
 
Fixed Asset Disposal2.2M76.2K446.6K109.6K
 
 
 
 
 
Net Assets From Acquisitions 0.00-137.2M0.000.00
 
 
Other Investing - Uses0.00-88.9K-217.3K-69.7K
 
 
 
 
Other Investing - Sources141.5K88.9K24.1K0.00
 
 
 
 
Net Cash Flow Investing-90.5M-130.5M-55.5M-66.7M
 
 
 
 
 
 
FinancingShort Term Borrowings-6.1M0.000.000.00
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale66.5M0.000.000.00
 
 
Common Preferred Redeemed-294.8K-25.4K-166.1M-59.8K
 
 
 
 
 
Common Dividends-80.3M-110.6M-102.2M-82.1M
 
 
 
 
 
Cash Dividends Paid - Total-80.3M-110.6M-102.2M-82.1M
 
 
 
 
 
Other Sources - Financing1.7M1.9M8.1M3.0M
 
 
 
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-18.5M-108.7M-260.2M-79.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-4.6M-1.3M11.7M12.8M
 
 
 
 
 
 
Net Change In Cash100.5M33.7M-195.7M112.7M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account